NCT06950034
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06950034
Title A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Solu Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.